- FARXIGA for CKD | Heart Failure | Type 2 Diabetes
FARXIGA® (dapagliflozin), a medication for people with chronic kidney disease (CKD), heart failure with symptoms, and type 2 diabetes
- FARXIGA
For adults with type 2 diabetes, FARXIGA reduces the risk of hospitalization for heart failure in those with heart disease or risk factors for it FARXIGA also improves blood sugar control in adults and children aged 10 years and older with type 2 diabetes when used along with diet and exercise
- FAQs | FARXIGA® (dapagliflozin)
The most common side effects of FARXIGA include yeast infections of the vagina or penis, and changes in urination, including urgent need to urinate more often, in larger amounts, or at night
- StartSmart | FARXIGA® (dapagliflozin)
Learn how FARXIGA® (dapagliflozin) can help adults with CKD or HF Discover resources, tips and support to get started on right path
- Understanding heart failure, and what you can do - FARXIGA
The most common side effects of FARXIGA include yeast infections of the vagina or penis, and changes in urination, including urgent need to urinate more often, in larger amounts, or at night
- Possible Side Effects of FARXIGA® (dapagliflozin)
The most common side effects of FARXIGA include yeast infections of the vagina or penis, and changes in urination, including urgent need to urinate more often, in larger amounts, or at night
- FARXIGA
For adults with chronic kidney disease (CKD), FARXIGA is a prescription medicine approved to reduce the risk of further worsening of kidney disease, end-stage kidney disease, death due to cardiovascular disease, and hospitalization for heart failure
- FARXIGA HF Facts | FARXIGA StartSmart
How does FARXIGA work? FARXIGA is part of a class of medications called sodium-glucose cotransporter 2 (SGLT2) inhibitors It blocks some of the sugar reabsorption in the kidneys and flushes away the sugar in the urine
|